SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending following the announcement that the Depository Trust & Clearing Corporation (DTCC) plans to integrate its asset tokenization platform with the Stellar blockchain. The community is actively discussing this as a major institutional validation of Stellar's utility, sparking excitement about real-world asset integration and fueling speculation of a potential short squeeze.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is seeing increased investor attention as the market shifts toward the tokenization of real-world assets and the potential for institutional blockchain adoption. Community sentiment remains polarized between long-term holders focused on enterprise utility partnerships and skeptics concerned about token supply, short-term price volatility, and regulatory uncertainty.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors rally around the companys pivot to AI and robotics, with the community highlighting its QNX operating system as a critical foundation for next-generation physical AI and autonomous vehicles. The stock is seeing significant momentum and bullish sentiment as long-term holders anticipate a potential breakout, driven by the belief that the companys safety-certified technology is increasingly vital to major industry partners.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is currently facing significant community backlash and market pressure, fueled by investor frustration over stagnant price action, consistent token dilution, and a perceived shift of institutional interest toward other assets like XLM. While some holders maintain conviction in long-term utility and potential regulatory breakthroughs, sentiment is heavily polarized as discussions pivot between deep skepticism of leadership and ongoing speculation about future partnerships.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood (HOOD) is rallying on significant retail and institutional interest, fueled by the launch of government-backed 'Trump Accounts' and the debut of new agentic AI trading features. The community is actively discussing a potential breakout toward triple-digit price levels, with many traders optimistic about the platform's long-term potential as a dominant financial super app.

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is surging as retail traders pile into the stock, fueled by a potent mix of high short interest, massive trading volume, and speculative excitement surrounding the upcoming SpaceX IPO. The community remains deeply divided, with bulls pointing to the company's aspirational space tourism narrative and turnaround potential while skeptics warn of potential dilution, meme-stock volatility, and the risks of chasing a hyped rally.

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.

Oculis Holding AG

Oculis Holding is experiencing significant volatility following a primary endpoint failure in a key clinical trial for diabetic macular edema. The community is actively debating the company's long-term outlook, weighing the potential impact of its remaining pipeline against concerns regarding its current market valuation and trial setbacks.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is facing significant downward pressure as investors rotate out of the SaaS sector, driven by heightened concerns over AI's potential to disrupt traditional software business models. The community remains deeply polarized, with some bulls highlighting the company's strong cash position and growth fundamentals as a long-term value opportunity, while bears argue that the stock's guidance and competitive positioning are increasingly vulnerable to the shifting AI landscape.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is currently capturing significant market attention as investors weigh robust earnings growth and aggressive AI infrastructure demand against recent stock price volatility. The community remains deeply divided, with long-term holders emphasizing strong fundamentals and multi-year growth prospects, while active traders focus on navigating sharp daily price swings and potential institutional profit-taking.

American Eagle Outfitters, Inc. is a multi-brand specialty retailer, which offers an assortment of apparel and accessories for men and women under the American Eagle Outfitters brand, and intimates, apparel and personal care products for women under the Aerie brand. The firm operates stores in the United States, Canada, Mexico, Hong Kong, China and the United Kingdom. It also acquired two emerging brands to complement its existing brands, Tailgate, a vintage sports-inspired apparel brand, and Todd Snyder New York, a premium menswear brand. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is experiencing a surge in investor interest and stock momentum, largely fueled by a stronger-than-expected earnings report and record revenue growth. The market is reacting positively to the brand's successful marketing campaigns and celebrity collaborations, which have significantly bolstered new customer acquisition and sustained brand heat heading into the holiday season.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

eXoZymes (Nasdaq: $EXOZ ) CCO Damien Perriman details the NCTx commercialization model after a Cayman Chemical scale-up reached roughly 99% conversion and 99.6% purity. 
 
eXoZymes Inc. (NASDAQ: EXOZ) Chief Commercial Officer Damien Perriman appeared on the Grow Everything podcast, co-hosted by Erum Azeez Khan and Karl Schmieder, to discuss the company’s first spinout, NCTx, and the commercialization model behind its cell-free biomanufacturing platform. 
 
eXoZymes Inc. is a B2i Digital Featured Company. See the company’s profile at https://b2idigital.com/exozymes-1. 
 
Perriman explained why eXoZymes launched NCTx as a dedicated vehicle for NCT while keeping eXoZymes focused on what it does best: developing better ways to manufacture difficult-to-access molecules with real commercial potential. He outlined a supplement-first path for NCT, citing an established GRAS pathway and a potentially faster route to market, with a longer pharmaceutical track running in parallel. 
 
He also pointed to recent third-party validation with Cayman Chemical, which independently transferred and ran the NCT process at 100-fold scale, reaching approximately 99% conversion and 99.6% purity on the first attempt. Perriman described the result as a proof point that the platform can support tech transfer and external manufacturing. 
 
On the episode, Perriman put it this way: “When our process performs successfully in someone else’s hands at scale, it reinforces that cell-free biomanufacturing can be a practical commercial platform.” 
 
Watch the full interview here: https://youtu.be/eDsyoZzwOJM?si=5GgoaTuGoyZQykyJ 
 
Read more at https://exozymes.com/blog/grow-everything-podcast-perriman-2026 
 
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com. 
 
eXoZymes is a Los Angeles, California-based biotechnology company developing cell-free biomanufacturing technology that uses AI-engineered enzymes to transform abundant feedstock into high-value nutraceuticals and novel medicines. The company is currently focused on products including NCT, non-intoxicating cannabinoids, and sustainable aviation fuel. 
 
eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, CSO and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Lasse H. Görlitz, VP of Communications; and Amy Lunzer, Chief of Staff. 
 
Learn more at https://exozymes.com. For investor inquiries, visit https://exozymes.com/investor. 
 
Disclosure: David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted EXOZ stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. See the complete Disclosure at https://b2idigital.com/disclaimer. B2i Digital is not a broker-dealer or investment adviser. 
 
$DNLI, $TWST, $DNA, $ARKG

David Shapiro

top moon

Dwight

Alfredo

Edward

Bonnie Siegmund

Ariana Storck

Craig Salinas

Eugene Davenport

Michael Musto

Roberta Creech

Henry Callaghan

John Park

Melissa Vermillion

Shirley Hall

Jeanne Hodges

Micheal Fikes

James Adair

Kelly Distaffen

Renee Blankenship

Nina Studdard

Filomena Marsh

Raymond Oliver

Lucy Pena

Terry Skora

Edwina Packard

Amber Reilly

Karen Paris

Lillian Ellis

Sue Guajardo

eXoZymes Inc. management brings together biotechnology and commercial expertise. The team combines scientific leadership from UCLA with business executives experienced in scaling technology companies, leveraging deep knowledge in enzyme engineering, artificial intelligence, and biomanufacturing to develop and commercialize cell-free production solutions for partners worldwide The eXoZymes Inc.

B2idigital

eXoZymes Inc. | Nasdaq: EXOZ | B2i Digital Featured Company

Damien Perriman, Chief Commercial Officer of eXoZymes and the commercial lead behind the NCTx spinout, breaks down why cell-free biomanufacturing changes the rules for scaling nature's rare molecules.

YouTube

176. Dare to Commercialize: Damien Perriman's eXoZymes Playbook

On the Grow Everything podcast, CCO of eXoZymes, Damien Perriman, breaks down why cell-free biomanufacturing changes the rules for scaling nature's rare molecules.

Exozymes

eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcast

b2i digital - connecting companies and investors through digital marketing, investor conferences, and direct introductions and meetings.

B2i Digital - Connecting companies and investors

eXoZymes is redefining how complex molecules are discovered, manufactured, and commercialized. Its AI-enhanced, cell-free biomanufacturing platform turns rare, unscalable, or economically inaccessible chemistry into predictable, high-purity production. By embedding manufacturability directly into discovery, eXoZymes collapses development timelines, lowers capital intensity, and unlocks multiple commercialization paths.

Home - eXoZymes leading the next generation of biomanufacturing

Chemicals are everywhere around us. They're in our medicine, fuel, plastic, food, and most colors, to name a few applications. Biochemical extraction is often inefficient, and petrochemical production is toxic and polluting.

Investor

Disclaimer - Content is provided "as is" by companies featured on the site. Conduct a trusted advisory before making investments.

Disclaimer - Consult an advisor before making any investments

StockTwits Web

eXoZymes Inc.

Denali Therapeutics Inc

Twist Bioscience Corp

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

ARK Investment Management LLC - ARK Genomic Revolution ETF

 ) CCO Damien Perriman details the NCTx commercialization model after a Cayman Chemical scale-up reached roughly 99% conversion and 99.6% purity. 
 
eXoZymes Inc. (NASDAQ: EXOZ) Chief Commercial Officer Damien Perriman appeared on the Grow Everything podcast, co-hosted by Erum Azeez Khan and Karl Schmieder, to discuss the company’s first spinout, NCTx, and the commercialization model behind its cell-free biomanufacturing platform. 
 
eXoZymes Inc. is a B2i Digital Featured Company. See the company’s profile at 

. 
 
Perriman explained why eXoZymes launched NCTx as a dedicated vehicle for NCT while keeping eXoZymes focused on what it does best: developing better ways to manufacture difficult-to-access molecules with real commercial potential. He outlined a supplement-first path for NCT, citing an established GRAS pathway and a potentially faster route to market, with a longer pharmaceutical track running in parallel. 
 
He also pointed to recent third-party validation with Cayman Chemical, which independently transferred and ran the NCT process at 100-fold scale, reaching approximately 99% conversion and 99.6% purity on the first attempt. Perriman described the result as a proof point that the platform can support tech transfer and external manufacturing. 
 
On the episode, Perriman put it this way: “When our process performs successfully in someone else’s hands at scale, it reinforces that cell-free biomanufacturing can be a practical commercial platform.” 
 
Watch the full interview here: 

 
 
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at 

. 
 
eXoZymes is a Los Angeles, California-based biotechnology company developing cell-free biomanufacturing technology that uses AI-engineered enzymes to transform abundant feedstock into high-value nutraceuticals and novel medicines. The company is currently focused on products including NCT, non-intoxicating cannabinoids, and sustainable aviation fuel. 
 
eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, CSO and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Lasse H. Görlitz, VP of Communications; and Amy Lunzer, Chief of Staff. 
 
Learn more at 

/investor. 
 
Disclosure: David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted EXOZ stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. See the complete Disclosure at 

/disclaimer. B2i Digital is not a broker-dealer or investment adviser. 
 


eXoZymes Inc. continues to demonstrate how scalable cell-free biomanufacturing can move from concept to commercial execution. The successful Cayman Chemical scale-up adds meaningful third-party validation to the company’s platform and the NCTx commercialization strategy. 
 
See eXoZymes Inc.’s full Featured Company profile at: https://b2idigital.com/exozymes-1 and learn more about its work in nutraceuticals, cannabinoids, and sustainable aviation fuel.

eXoZymes Inc. continues to demonstrate how scalable cell-free biomanufacturing can move from concept to commercial execution. The successful Cayman Chemical scale-up adds meaningful third-party validation to the company’s platform and the NCTx commercialization strategy. 
 
See eXoZymes Inc.’s full Featured Company profile at: 

 and learn more about its work in nutraceuticals, cannabinoids, and sustainable aviation fuel.